| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HED.20022 |
| P698 | PubMed publication ID | 15229902 |
| P50 | author | Alexander C Vlantis | Q57896004 |
| P2093 | author name string | C Andrew van Hasselt | |
| K F To | |||
| Raymond K Y Tsang | |||
| John S L Tam | |||
| Ricky W K Ho | |||
| P2860 | cites work | Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells | Q36385482 |
| Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma | Q40037599 | ||
| Nasopharyngeal carcinoma: Significance of changes in epstein-barr virus-related antibody patterns following therapy | Q40112258 | ||
| Serologic Markers of Epstein–Barr Virus Infection and Nasopharyngeal Carcinoma in Taiwanese Men | Q45734371 | ||
| Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies | Q45826327 | ||
| Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China | Q50589472 | ||
| Staging and IgA VCA titre in patients with nasopharyngeal carcinoma: changes over a 12-year period | Q77942700 | ||
| P433 | issue | 7 | |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 598-602 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | Head & Neck | Q13703062 |
| P1476 | title | Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review | |
| P478 | volume | 26 |
| Q33967422 | Combination of autoantibodies against NY-ESO-1 and viral capsid antigen immunoglobulin A for improved detection of nasopharyngeal carcinoma |
| Q35463816 | Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray |
| Q36373732 | Development of a non-invasive method, multiplex methylation specific PCR (MMSP), for early diagnosis of nasopharyngeal carcinoma |
| Q35963843 | Diagnostic values of serum cathepsin B and D in patients with nasopharyngeal carcinoma |
| Q34081186 | Evaluation and integration of genetic signature for prediction risk of nasopharyngeal carcinoma in Southern China |
| Q33310726 | Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis. |
| Q34286259 | Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population |
| Q33470022 | SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma. |
| Q95856254 | Septin 9 Methylation in Nasopharyngeal Swabs: A Potential Minimally Invasive Biomarker for the Early Detection of Nasopharyngeal Carcinoma |
| Q26829346 | Serological diagnosis of Epstein-Barr virus infection: Problems and solutions |
| Q92715203 | Serum IRS-1 acts as a novel biomarker for diagnosis in patients with nasopharyngeal carcinoma |
| Q35783467 | Serum antibody response to lytic and latent Epstein-Barr virus antigens in undifferentiated nasopharyngeal carcinoma patients from an area of nonendemicity |
| Q37621102 | Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma |
| Q33243876 | Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinoma |
| Q38039507 | Systematic Review on Epstein-Barr Virus (EBV) DNA in Diagnosis of Nasopharyngeal Carcinoma in Asian Populations |
| Q37690544 | Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus |
Search more.